
News|Articles|April 2, 2003
- Pharmaceutical Technology-04-02-2003
- Volume 27
- Issue 4
Overhauling Compliance and GMPs
Author(s)Jill Wechsler
FDA's newly launched risk-based approach to GMP regulation spurs signficant changes in the agency's approach to inspection processes, postapproval changes, and 21 CFR Part 11 enforcement.
Advertisement
Articles in this issue
over 23 years ago
Outsourcing Outlookover 23 years ago
April 2003over 23 years ago
Identification of Out-of-Trend Stability ResultsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Activity Round Up – July 2026
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
4
Midyear 2026 Check-In: Agentic AI Cuts Deviation Investigations by 50%
5




